Screener
Eton Pharmaceuticals, Inc. ETON Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 67,095 | 65,960 |
| Commitments and contingencies (Note 13) | ||
| Stockholders’ equity | ||
| Common stock, $0.001 par value; 50,000,000 shares authorized; 27,359,791 and 27,047,061 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 27 | 27 |
| Additional paid-in capital | 141,528 | 138,621 |
| Accumulated deficit | (110,940) | (112,494) |
| Total stockholders’ equity | 30,615 | 26,154 |
| Total liabilities and stockholders’ equity | $97,710 | $92,114 |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s common stock?
- Eton Pharmaceuticals, Inc. (ETON) reported common stock of $27K in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s common stock changed year-over-year?
- Eton Pharmaceuticals, Inc.'s common stock decreased by 0.0% year-over-year, from $27K to $27K.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s common stock?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s common stock has grown at a -77.8% compound annual growth rate (CAGR), from $50M to $27K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Eton Pharmaceuticals, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude